{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:28:06Z","timestamp":1794245286677,"version":"4.9.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07575-z","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T17:04:18Z","timestamp":1766423058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["EpCAM activates the ERK-EGR1 signaling axis and promotes TNF-\u03b1-induced the progression of anaplastic thyroid cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Chi-Chiu","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushree Shankar","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Yi","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hsuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruey-Long","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hsi","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassian","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Y.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"7575_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1083\/jcb.125.2.437","volume":"125","author":"SV Litvinov","year":"1994","unstructured":"Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO. Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol. 1994;125:437\u201346.","journal-title":"J Cell Biol"},{"key":"7575_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.critrevonc.2018.03.006","volume":"126","author":"A Herreros-Pomares","year":"2018","unstructured":"Herreros-Pomares A, Aguilar-Gallardo C, Calabuig-Farinas S, Sirera R, Jantus-Lewintre E, Camps C. EpCAM duality becomes this molecule in a new Dr. Jekyll and mr. Hyde tale. Crit Rev Oncol Hematol. 2018;126:52\u201363.","journal-title":"Crit Rev Oncol Hematol"},{"key":"7575_CR3","doi-asserted-by":"crossref","unstructured":"Gires O, Pan M, Schinke H, Canis M, Baeuerle PA. Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years? Cancer Metastasis Rev. 2020;1\u201319.","DOI":"10.1007\/s10555-020-09898-3"},{"key":"7575_CR4","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1073\/pnas.76.3.1438","volume":"76","author":"M Herlyn","year":"1979","unstructured":"Herlyn M, Steplewski Z, Herlyn D, Koprowski H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci USA. 1979;76:1438\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7575_CR5","doi-asserted-by":"publisher","first-page":"24574","DOI":"10.1074\/jbc.M115.662700","volume":"290","author":"T Tsaktanis","year":"2015","unstructured":"Tsaktanis T, Kremling H, Pavsic M, von Stackelberg R, Mack B, Fukumori A, Steiner H, Vielmuth F, Spindler V, Huang Z, et al. Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM). J Biol Chem. 2015;290:24574\u201391.","journal-title":"J Biol Chem"},{"key":"7575_CR6","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1128\/MCB.21.7.2570-2580.2001","volume":"21","author":"M Balzar","year":"2001","unstructured":"Balzar M, Briaire-de Bruijn IH, Rees-Bakker HA, Prins FA, Helfrich W, de Leij L, Riethmuller G, Alberti S, Warnaar SO, Fleuren GJ, Litvinov SV. Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol. 2001;21:2570\u201380.","journal-title":"Mol Cell Biol"},{"key":"7575_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ncb1824","volume":"11","author":"D Maetzel","year":"2009","unstructured":"Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M, Gires O. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol. 2009;11:162\u201371.","journal-title":"Nat Cell Biol"},{"key":"7575_CR8","doi-asserted-by":"crossref","unstructured":"Liang K-H, Lai J-K, Kuan I, Tso H-C, Wu H-C. EpCAM\/EpEX regulate tumor progression through EGFR signaling in colon cancer cells [abstract]. vol. Abstract nr 327. Proceedings of the American Association for Cancer Research Annual Meeting. AACR; 2017; 2017.","DOI":"10.1158\/1538-7445.AM2017-327"},{"key":"7575_CR9","doi-asserted-by":"crossref","unstructured":"Liang KH, Tso HC, Hung SH, Kuan L II, Ke JK, Chuang FY, Liu YT, Wang IJ, Chen YP, Wu RH, HC. Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells. Cancer Lett. 2018;433:165\u201375.","DOI":"10.1016\/j.canlet.2018.06.040"},{"key":"7575_CR10","doi-asserted-by":"publisher","first-page":"e2006624","DOI":"10.1371\/journal.pbio.2006624","volume":"16","author":"M Pan","year":"2018","unstructured":"Pan M, Schinke H, Luxenburger E, Kranz G, Shakhtour J, Libl D, Huang Y, Gaber A, Pavsic M, Lenarcic B, et al. EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1\/2 in head and neck cancers. PLoS Biol. 2018;16:e2006624.","journal-title":"PLoS Biol"},{"key":"7575_CR11","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1158\/0008-5472.CAN-20-1264","volume":"80","author":"H-N Chen","year":"2020","unstructured":"Chen H-N, Liang K-H, Lai J-K, Lan C-H, Liao M-Y, Hung S-H, Chuang Y-T, Chen K-C, Tsuei W-F, Wu H-C. EpCAM signaling promotes tumor progression and protein stability of PD-L1 through the EGFR pathway. Cancer Res. 2020;80:5035\u201350.","journal-title":"Cancer Res"},{"key":"7575_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-023-04390-2","volume":"21","author":"C-C Lee","year":"2023","unstructured":"Lee C-C, Yu C-J, Panda SS, Chen K-C, Liang K-H, Huang W-C, Wang Y-S, Ho P-C, Wu H-C. Epithelial cell adhesion molecule (EpCAM) regulates HGFR signaling to promote colon cancer progression and metastasis. J Transl Med. 2023;21:1\u201322.","journal-title":"J Transl Med"},{"key":"7575_CR13","doi-asserted-by":"publisher","first-page":"39449","DOI":"10.1074\/jbc.M112.386235","volume":"287","author":"CW Lin","year":"2012","unstructured":"Lin CW, Liao MY, Lin WW, Wang YP, Lu TY, Wu HC. Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer. J Biol Chem. 2012;287:39449\u201359.","journal-title":"J Biol Chem"},{"key":"7575_CR14","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.3390\/cells9092128","volume":"9","author":"F Fagotto","year":"2020","unstructured":"Fagotto F. EpCAM as modulator of tissue plasticity. Cells. 2020;9:2128.","journal-title":"Cells"},{"key":"7575_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12929-024-01057-y","volume":"31","author":"SS Panda","year":"2024","unstructured":"Panda SS, Lee C-C, Geevimaan K, Chen K-C, Yang S-H, Shen C-N, HuangFu W-C, Wu H-C. Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression. J Biomed Sci. 2024;31:72.","journal-title":"J Biomed Sci"},{"key":"7575_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ecl.2008.02.003","volume":"37","author":"RL Neff","year":"2008","unstructured":"Neff RL, Farrar WB, Kloos RT, Burman KD. Anaplastic thyroid cancer. Endocrinol Metab Clin N Am. 2008;37:525\u201338.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"7575_CR17","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1001\/jamaoncol.2020.3362","volume":"6","author":"A Maniakas","year":"2020","unstructured":"Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, Williams MD, Gunn GB, Hofmann M-C, Cote G. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019. J JAMA Oncol. 2020;6:1397\u2013404.","journal-title":"J JAMA Oncol"},{"key":"7575_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1245\/ASO.2006.05.042","volume":"13","author":"C Are","year":"2006","unstructured":"Are C, Shaha AR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol. 2006;13:453\u201364.","journal-title":"Ann Surg Oncol"},{"key":"7575_CR19","doi-asserted-by":"crossref","unstructured":"He HCH, Kashat L, Kak I, Kunavisarut T, Gundelach R, Kim D, So AKC, MacMillan C, Freeman JL, Ralhan R. An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma. PLoS One. 2012;7.","DOI":"10.1371\/journal.pone.0042893"},{"key":"7575_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3803\/EnM.2020.35.1.14","volume":"35","author":"WB Kim","year":"2020","unstructured":"Kim WB, Jeon MJ, Kim WG, Kim TY, Shong YK. Unmet clinical needs in the treatment of patients with thyroid cancer. Endocrinol Metab (enm). 2020;35:14\u201325.","journal-title":"Endocrinol Metab (enm)"},{"key":"7575_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3803\/EnM.2021.103","volume":"36","author":"EK Lee","year":"2021","unstructured":"Lee EK, Park YJ. Best achievements in clinical thyroidology in 2020. Endocrinol Metab (enm). 2021;36:30\u201335.","journal-title":"Endocrinol Metab (enm)"},{"key":"7575_CR22","doi-asserted-by":"crossref","unstructured":"Lu L, Wang JR, Henderson YC, Bai S, Yang J, Hu M, Shiau C-K, Pan T, Yan Y, Tran TM. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. The J Clin Investigation. 2023;133.","DOI":"10.1172\/JCI169653"},{"key":"7575_CR23","doi-asserted-by":"publisher","first-page":"e4652","DOI":"10.1210\/clinem\/dgab453","volume":"106","author":"A Maniakas","year":"2021","unstructured":"Maniakas A, Henderson YC, Hei H, Peng S, Chen Y, Jiang Y, Ji S, Cardenas M, Chiu Y, Bell D. Novel anaplastic thyroid cancer PDXs and cell lines: expanding preclinical models of genetic diversity. J Clin Endocrinol Metab. 2021;106:e4652\u2013e 4665.","journal-title":"J Clin Endocrinol Metab"},{"key":"7575_CR24","doi-asserted-by":"publisher","first-page":"E243","DOI":"10.1210\/jc.2014-2624","volume":"100","author":"YC Henderson","year":"2015","unstructured":"Henderson YC, Ahn S-H, Ryu J, Chen Y, Williams MD, El-Naggar AK, Gagea M, Schweppe RE, Haugen BR, Lai SY, Clayman GL. Development and characterization of six New human Papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab. 2015;100:E243\u201352.","journal-title":"J Clin Endocrinol Metab"},{"key":"7575_CR25","doi-asserted-by":"crossref","unstructured":"Liao M-Y, Lai J-K, Kuo M-P, Lu R-M, Lin C-W, Cheng P-C, Liang K-H, Wu H-C. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer. Oncotarget. 2015;6.","DOI":"10.18632\/oncotarget.4453"},{"key":"7575_CR26","doi-asserted-by":"publisher","first-page":"49523","DOI":"10.1074\/jbc.M402034200","volume":"279","author":"Y-F Liao","year":"2004","unstructured":"Liao Y-F, Wang B-J, Cheng H-T, Kuo L-H, Wolfe MS. Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem. 2004;279:49523\u201332.","journal-title":"J Biol Chem"},{"key":"7575_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"7575_CR28","unstructured":"Carlson M. Genome wide annotation for humanR package version 3.5. 0. 2017."},{"key":"7575_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y. He Q-Y: clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: A J Intgr Biol. 2012;16:284\u201387.","journal-title":"Omics: A J Intgr Biol"},{"key":"7575_CR30","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7575_CR31","first-page":"726","volume":"1","author":"R Kolde","year":"2019","unstructured":"Kolde R. Pheatmap: pretty heatmaps. R Package Version. 2019;1:726.","journal-title":"R Package Version"},{"key":"7575_CR32","unstructured":"Yu g: enrichplot: visualization of functional enrichment result. R package version 1.20. 3. Mol Ther Nucleic Acids. 2023."},{"key":"7575_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41598-018-36753-x","volume":"9","author":"T Sekiya","year":"2019","unstructured":"Sekiya T, Kato K, Kawaguchi A, Nagata K. Involvement of CTCF in transcription regulation of EGR1 at early G1 phase as an architecture factor. Sci Rep. 2019;9:329.","journal-title":"Sci Rep"},{"key":"7575_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-0716-1205-7_14","volume-title":"Melanoma: methods and protocols","author":"N Mukherjee","year":"2021","unstructured":"Mukherjee N, Lambert KA, Norris DA, Shellman YG. Enrichment of melanoma stem-like cells via sphere assays. In: Melanoma: methods and protocols. Springer; 2021. p. 185\u201399."},{"key":"7575_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21769\/BioProtoc.1659","volume":"5","author":"L Agro","year":"2015","unstructured":"Agro L, O\u2019Brien C. In vitro and in vivo limiting dilution assay for colorectal cancer. Bio Protoc. 2015;5:1\u201311.","journal-title":"Bio Protoc"},{"key":"7575_CR36","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle E. Clevers HJNm: cancer stem cells revisited. Nat Med. 2017;23:1124\u201334.","journal-title":"Nat Med"},{"key":"7575_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/1471-2407-9-402","volume":"9","author":"S Denzel","year":"2009","unstructured":"Denzel S, Maetzel D, Mack B, Eggert C, Barr G, Gires O. Initial activation of EpCAM cleavage via cell-to-cell contact. BMC Cancer. 2009;9:402.","journal-title":"BMC Cancer"},{"key":"7575_CR38","doi-asserted-by":"publisher","first-page":"14608","DOI":"10.1074\/jbc.275.19.14608","volume":"275","author":"P Reddy","year":"2000","unstructured":"Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, Shows D, Peschon JJ, Black RA. Functional analysis of the domain structure of tumor necrosis factor-\u03b1 converting enzyme. J Biol Chem. 2000;275:14608\u201314.","journal-title":"J Biol Chem"},{"key":"7575_CR39","doi-asserted-by":"publisher","first-page":"102409","DOI":"10.1016\/j.coi.2023.102409","volume":"86","author":"LF Alim","year":"2024","unstructured":"Alim LF, Keane C, Souza-Fonseca-Guimaraes F. Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment. Curr Opin Immunol. 2024;86:102409.","journal-title":"Curr Opin Immunol"},{"key":"7575_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.molonc.2014.09.002","volume":"9","author":"V Bigatto","year":"2015","unstructured":"Bigatto V, De Bacco F, Casanova E, Reato G, Lanzetti L, Isella C, Sarotto I, Comoglio PM, Boccaccio C. TNF-\u03b1 promotes invasive growth through the met signaling pathway. J Mol Oncol. 2015;9:377\u201388.","journal-title":"J Mol Oncol"},{"key":"7575_CR41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41418-022-01088-8","volume":"30","author":"E Jung","year":"2023","unstructured":"Jung E, Ou S, Ahn SS, Yeo H, Lee YH, Shin SY. The JNK-EGR1 signaling axis promotes TNF-\u03b1-induced endothelial differentiation of human mesenchymal stem cells via VEGFR2 expression. J Cell Death Differentiation. 2023;30:356\u201368.","journal-title":"J Cell Death Differentiation"},{"key":"7575_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrc2499-c1","volume":"9","author":"O Gires","year":"2009","unstructured":"Gires O, Klein CA, Baeuerle PA. On the abundance of EpCAM on cancer stem cells. Nat Rev Cancer. 2009;9:143.","journal-title":"Nat Rev Cancer"},{"key":"7575_CR43","doi-asserted-by":"crossref","unstructured":"Cancer Genome atlas N: comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330\u201337.","DOI":"10.1038\/nature11252"},{"key":"7575_CR44","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29:4741\u201351.","journal-title":"Oncogene"},{"key":"7575_CR45","doi-asserted-by":"publisher","first-page":"10158","DOI":"10.1073\/pnas.0703478104","volume":"104","author":"P Dalerba","year":"2007","unstructured":"Dalerba P, Dylla SJ, Park I-K, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA. 2007;104:10158\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7575_CR46","first-page":"1","volume":"10","author":"R Ralhan","year":"2010","unstructured":"Ralhan R, Cao J, Lim T, MacMillan C, Freeman JL, Walfish PG. EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis. J BMC Cancer. 2010;10:1\u201311.","journal-title":"J BMC Cancer"},{"key":"7575_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11515-018-1513-3","volume":"13","author":"D Gao","year":"2018","unstructured":"Gao D, Mittal V, Ban Y, Lourenco AR, Yomtoubian S, Lee S. Metastatic tumor cells-genotypes and phenotypes. Front Biol. 2018;13:277\u201386.","journal-title":"Front Biol"},{"key":"7575_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","volume":"101","author":"M Iwatsuki","year":"2010","unstructured":"Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H, Mori M. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101:293\u201399.","journal-title":"Cancer Sci"},{"key":"7575_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7:131\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7575_CR50","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1038\/s41467-019-09438-w","volume":"10","author":"MJ Sale","year":"2019","unstructured":"Sale MJ, Balmanno K, Saxena J, Ozono E, Wojdyla K, McIntyre RE, Gilley R, Woroniuk A, Howarth KD, Hughes G. MEK1\/2 inhibitor withdrawal reverses acquired resistance driven by BRAFV600E amplification whereas KRASG13D amplification promotes EMT-chemoresistance. Nat Commun. 2019;10:2030.","journal-title":"Nat Commun"},{"key":"7575_CR51","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.celrep.2016.11.056","volume":"17","author":"A Segerman","year":"2016","unstructured":"Segerman A, Niklasson M, Haglund C, Bergstr\u00f6m T, Jarvius M, Xie Y, Westermark A, S\u00f6nmez D, Hermansson A, Kastemar M. Clonal variation in drug and radiation response among glioma-initiating cells is linked to proneural-mesenchymal transition. Cell Rep. 2016;17:2994\u20133009.","journal-title":"Cell Rep"},{"key":"7575_CR52","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14:611\u201329.","journal-title":"Nat Rev Clin Oncol"},{"key":"7575_CR53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41419-017-0013-8","volume":"9","author":"M-H Wang","year":"2018","unstructured":"Wang M-H, Sun R, Zhou X-M, Zhang M-Y, Lu J-B, Yang Y, Zeng L-S, Yang X-Z, Shi L, Xiao R-W. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN\/AKT\/mTOR pathway. J Cell Death. 2018;9:2.","journal-title":"J Cell Death"},{"key":"7575_CR54","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.21037\/gs.2019.10.18","volume":"9","author":"SM Ferrari","year":"2020","unstructured":"Ferrari SM, Elia G, Ragusa F, Ruffilli I, La Motta C, Paparo SR, Patrizio A, Vita R, Benvenga S, Materazzi G. Novel treatments for anaplastic thyroid carcinoma. Gland Surg. 2020;9:S28.","journal-title":"Gland Surg"},{"key":"7575_CR55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1158\/2159-8290.CD-11-0341","volume":"2","author":"RB Corcoran","year":"2012","unstructured":"Corcoran RB, Ebi H, Turke AB, Coffee EM, Nishino M, Cogdill AP, Brown RD, Della Pelle P, Dias-Santagata D, Hung KE. EGFR-mediated reactivation of MAPK signaling contributes to insensitivity of BRAF-mutant colorectal cancers to RAF inhibition with vemurafenib. Cancer Discov. 2012;2:227\u201335.","journal-title":"Cancer Discov"},{"key":"7575_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature10868","volume":"483","author":"A Prahallad","year":"2012","unstructured":"Prahallad A, Sun C, Huang S, Di Nicolantonio F, Salazar R, Zecchin D, Beijersbergen RL, Bardelli A, Bernards R. Unresponsiveness of colon cancer to BRAF (V600E) inhibition through feedback activation of EGFR. Nature. 2012;483:100\u201303.","journal-title":"Nature"},{"key":"7575_CR57","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985\u201399.","journal-title":"Cell"},{"key":"7575_CR58","doi-asserted-by":"crossref","unstructured":"Diaz D, Bergdorf K, Loberg MA, Phifer CJ, Xu GJ, Sheng Q, Chen S-C, Byrant JM, Tigue ML, Hartmann H. Wnt\/\u03b2-catenin signaling is a therapeutic target in anaplastic thyroid carcinoma. Endocrine. 2024;1\u20135.","DOI":"10.1007\/s12020-024-03887-0"},{"key":"7575_CR59","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361\u201371.","journal-title":"Nat Rev Cancer"},{"key":"7575_CR60","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.2174\/092986710793176339","volume":"17","author":"L Bertazza","year":"2010","unstructured":"Bertazza L, Mocellin S. The dual role of tumor necrosis factor (TNF) in cancer biology. Curr Med Chem. 2010;17:3337\u201352.","journal-title":"Curr Med Chem"},{"key":"7575_CR61","doi-asserted-by":"publisher","first-page":"E5944","DOI":"10.1073\/pnas.1806973115","volume":"115","author":"P Amin","year":"2018","unstructured":"Amin P, Florez M, Najafov A, Pan H, Geng J, Ofengeim D, Dziedzic SA, Wang H, Barrett VJ, Ito Y. Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex ii in TNF\u03b1-mediated apoptosis. Proc Natl Acad Sci US A. 2018;115:E5944\u201353.","journal-title":"Proc Natl Acad Sci US A"},{"key":"7575_CR62","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12967-023-04043-4","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang Y, Qin C, Zhao B, Li Z, Li T, Yang X, Zhao Y, Wang W. EGR1 induces EMT in pancreatic cancer via a P300\/SNAI2 pathway. J Transl Med. 2023;21:201.","journal-title":"J Transl Med"},{"key":"7575_CR63","doi-asserted-by":"publisher","first-page":"eabn 7983","DOI":"10.1126\/sciadv.abn7983","volume":"8","author":"X Wang","year":"2022","unstructured":"Wang X, Semba T, Manyam GC, Wang J, Shao S, Bertucci F, Finetti P, Krishnamurthy S, Phi LTH, Pearson TJSA. EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Sci Adv. 2022;8:eabn 7983.","journal-title":"Sci Adv"},{"key":"7575_CR64","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.annonc.2021.12.014","volume":"33","author":"V Subbiah","year":"2022","unstructured":"Subbiah V, Kreitman R, Wainberg Z, Cho J, Schellens J, Soria J, Wen P, Zielinski C, Cabanillas M, AJAoO B. Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase ii roar basket study. Ann Oncol. 2022;33:406\u201315.","journal-title":"Ann Oncol"},{"key":"7575_CR65","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1089\/thy.2020.0322","volume":"31","author":"C Dierks","year":"2021","unstructured":"Dierks C, Seufert J, Aumann K, Ruf J, Klein C, Kiefer S, Rassner M, Boerries M, Zielke A, La Rosee PJT. Combination of lenvatinib and pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma. Thyroid. 2021;31:1076\u201385.","journal-title":"Thyroid"},{"key":"7575_CR66","doi-asserted-by":"crossref","unstructured":"Leboulleux S, Godbert Y, Penel N, Hescot S, De La Fouchardiere C, Blonski M, Lamartina L, Cousin S, Do Cao C, Hadoux J. Benefits of pembrolizumab in progressive radioactive iodine refractory thyroid cancer: results of the AcS\u00e9 pembrolizumab study from Unicancer. Wolters Kluwer Health. 2021.","DOI":"10.1200\/JCO.2021.39.15_suppl.6082"},{"key":"7575_CR67","first-page":"26","volume":"5","author":"A Jayarangaiah","year":"2019","unstructured":"Jayarangaiah A, Sidhu G, Brown J, Barrett-Campbell O, Bahtiyar G, Youssef I, Arora S, Skwiersky S, McFarlane SI. Therapeutic options for advanced thyroid cancer. J Clin Endocrinol Metab. 2019;5:26.","journal-title":"J Clin Endocrinol Metab"},{"key":"7575_CR68","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, Durante C, Hartl D, Leboulleux S, Locati L, Newbold K, Papotti M, Berruti A. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30:1856\u201383.","journal-title":"Ann Oncol"},{"key":"7575_CR69","doi-asserted-by":"crossref","unstructured":"Bible KC, Kebebew E, Brierley J, Brito JP, Cabanillas ME, Clark TJ Jr, Di Cristofano A, Foote R, Giordano T, Kasperbauer J. American thyroid association guidelines for management of patients with anaplastic thyroid cancer: American thyroid association anaplastic thyroid cancer guidelines task force. Thyroid. 2021 2021;31:337\u201386.","DOI":"10.1089\/thy.2020.0944"},{"key":"7575_CR70","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1089\/thy.2016.0395","volume":"27","author":"SN Rao","year":"2017","unstructured":"Rao SN, Zafereo M, Dadu R, Busaidy NL, Hess K, Cote GJ, Williams MD, William WN, Sandulache V, Gross N. Patterns of treatment failure in anaplastic thyroid carcinoma. Thyroid. 2017;27:672\u201381.","journal-title":"Thyroid"},{"key":"7575_CR71","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3390\/cancers12082104","volume":"12","author":"M Al-Jundi","year":"2020","unstructured":"Al-Jundi M, Thakur S, Gubbi S, Klubo-Gwiezdzinska J. Novel targeted therapies for metastatic thyroid cancer-a comprehensive review. J Cancers. 2020;12:2104.","journal-title":"J Cancers"},{"key":"7575_CR72","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41575-021-00508-3","volume":"19","author":"T-W Lee","year":"2022","unstructured":"Lee T-W, Guan X-Y, Sjnrg M. Hepatology: cancer stem cells in hepatocellular carcinoma-from origin to clinical implications. Nat Rev Gastroenterol Hepatol. 2022;19:26\u201344.","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07575-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07575-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07575-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:04:04Z","timestamp":1770984244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07575-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7575"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07575-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Committee on the Ethics of Animal Experiments of Academia Sinica.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Related to this work, the Institute of Cellular and Organismic Biology, Academia Sinica, has filed a patent application and transferred the technology to a biotech company; Han-Chung Wu and Chi-Chiu Lee are named as inventors. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}